Paper Details
- Home
- Paper Details
Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis.
Author: BlockGeoffrey A, BulfamanteGaetano, CannizzoStefania, CiceriPaola, CozzolinoMario, D'Arminio MonforteAntonella, FalleniMonica, MarchettiGiulia, MartinelliCarla, MessaPiergiorgio, TosiDelfina
Original Abstract of the Article :
In chronic kidney disease (CKD), the first cause of mortality is cardiovascular disease induced mainly by vascular calcification (VC). Recently, iron-based phosphate binders have been proposed in advanced CKD to treat hyperphosphatemia. We studied the effect of iron citrate (iron) on the progression...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928632/
データ提供:米国国立医学図書館(NLM)
Iron Citrate: A Potential Weapon Against Vascular Calcification in Chronic Kidney Disease
Chronic kidney disease (CKD) is a serious health condition, and vascular calcification (VC) is a major contributor to cardiovascular disease, the leading cause of death in CKD patients. This research investigates the therapeutic potential of iron citrate in combating VC. The study focused on the effects of iron citrate on calcified vascular smooth muscle cells (VSMC) exposed to high phosphate (Pi) levels, a key factor driving VC.
The study demonstrated that iron citrate effectively arrested further calcification in VSMCs when added during the calcification process. The researchers also found that iron citrate promoted autophagy and reduced apoptosis in high-Pi-treated VSMCs, suggesting a multifaceted mechanism of action. The study further revealed that iron citrate counteracted high-Pi-induced downregulation of the prosurvival GAS6/AXL pathway and stimulated its de novo synthesis. These findings highlight the potential of iron citrate as a novel therapeutic agent to combat VC in CKD.
A New Hope in the Fight Against Vascular Calcification
This research offers a beacon of hope in the fight against VC in CKD. Iron citrate, a readily available and inexpensive compound, shows promising results in reducing calcification and promoting cell survival, offering a potential new avenue for treatment and prevention of VC. It's like finding a hidden spring in the desert that can help nourish and protect the surrounding ecosystem from the harsh conditions.
Keeping Vascular Calcification at Bay
While this study provides promising results, further research is needed to understand the long-term effects of iron citrate and its optimal use in CKD patients. However, the findings provide a valuable foundation for developing new therapeutic strategies to combat VC and improve the overall health outcomes of individuals with CKD.
Dr.Camel's Conclusion
Vascular calcification in CKD can feel like a relentless desert storm, eroding the health of blood vessels. This research offers a glimmer of hope, showing that iron citrate might be the desert oasis that can quench the thirst for a new approach to fighting this debilitating condition. While further research is needed, this study opens a new chapter in the fight against vascular calcification, promising a more promising future for CKD patients.
Date :
- Date Completed 2020-05-04
- Date Revised 2020-05-05
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.